299. 嚢胞性線維症 Cystic fibrosis Clinical trials / Disease details

臨床試験数 : 1,695 / 薬物数 : 1,527 - (DrugBank : 268) / 標的遺伝子数 : 111 - 標的パスウェイ数 : 174

3 trials found

diseases per page:

Showing 1 to 3 of 3 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03748199 (ClinicalTrials.gov)	November 8, 2018	5/11/2018	Clinical Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of POL6014 ...	Phase-Ib/IIa Study to Investigate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ora ...	Cystic Fibrosis	Drug: POL6014;Drug: Placebo	Santhera Pharmaceuticals	NULL	Completed	18 Years	55 Years	All	32	Phase 1/Phase 2	Germany
2	EUCTR2018-002550-71-DE (EUCTR)	12/09/2018	18/07/2018	A clinical study to investigate safety, tolerability and dose of orally inhaled multiple doses of PO ...	Phase-Ib/IIa study to investigate safety, tolerability, pharmacokinetics and pharmacodynamics of ora ...	Cystic Fibrosis;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]	Product Name: POL6014 INN or Proposed INN: lonodelestat Other descriptive name: CYCLO[L-ALANYL-L-SERYL ...	Santhera Pharmaceuticals (Switzerland) Ltd	NULL	Not Recruiting			Female: yes Male: yes	32	Phase 1;Phase 2	Germany
3	EUCTR2016-005110-22-DE (EUCTR)	20/11/2017	23/06/2017	A clinical study to investigate safety, tolerability and dose of orally inhaled multiple doses of PO ...	Phase-Ib/IIa study to investigate safety, tolerability, pharmacokinetics and pharmacodynamics of ora ...	Cystic fibrosis;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]	Product Name: POL6014	Santhera Pharmaceuticals (Switzerland) Ltd	NULL	Not Recruiting			Female: yes Male: yes	40	Phase 1;Phase 2	Germany

First Previous1Next Last